The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
Table 2
Baseline lesions characteristics and devices used.
Diabetes duration
for trend
<5 years
5 to 10 years
>10 years
Number ()
165 (54.6%)
72 (23.8%)
65 (21.5%)
Coronary artery
LM
11 (6.7%)
9 (12.5%)
4 (6.2%)
0.260
LAD
149 (90.3%)
67 (93.1%)
58(89.2%)
0.714
Proximal
119 (72.1%)
53 (73.6%)
53 (81.5%)
0.330
Middle
117 (70.9%)
37 (51.4%)
42 (64.6%)
0.015
Distal
48 (29.1%)
23 (31.9%)
20 (30.8%)
0.900
LCX
104 (63%)
48 (66.7%)
47 (72.3%)
0.404
Proximal
68 (41.2%)
31 (43.1%)
26 (40%)
0.934
Middle
64 (38.8%)
28 (38.9%)
26 (40%)
0.985
Distal
35 (21.2%)
19 (26.4%)
21 (32.3%)
0.202
RCA
107 (64.8%)
46 (63.9%)
46 (70.8%)
0.639
Proximal
60 (36.4%)
24 (33.3%)
22 (33.8%)
0.878
Middle
60 (36.4%)
31 (43.7%)
30 (46.2%)
0.313
Distal
43 (26.1%)
23 (31.9%)
25 (38.5%)
0.169
Severity of CAD
1VD
32 (19.4%)
12 (17%)
8(16.9)
0.497
2VD
54 (32.7%)
22 (30.5%)
26 (40%)
0.609
3VD
78 (47.3%)
38 (52.9%)
32 (49.2%)
0.772
Long lesion
86 (52.4%)
39 (54.2%)
39 (60%)
0.584
CTO
50 (30.3%)
22 (31%)
24 (37%)
0.604
Treatment
DES-DCB
27 (16.3%)
10 (14%)
12 (18.4%)
0.767
DES alone
130 (79%)
55 (76.3%)
48 (74%)
0.713
DCB alone
8 (5%)
7 (10%)
5 (8%)
0.364
DES and DCB length
0.765
DES and DCB diameter
0.909
Data are presented as (%). LM: left main; LAD: left anterior descendant; LCX: left circumflex; RCA: right coronary artery; 1VD: 1 vessel disease; 2VD: 2 vessels disease; 3VD: 3 vessels disease; CAD: coronary artery disease; CTO: chronic total occlusion; DES: drug-eluting stent; PTCA: DCB: drug-coated balloon. All statistical significances were tested using X2 test for trend.
